Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for GNC in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $0.55.
Current Consensus is
The current consensus among 0 investment analysts is to n/a stock in GNC. This rating has held steady since February 2021, when it changed from a Sell consensus rating.
GNC Holdings, Inc., together with its subsidiaries, operates as a specialty retailer of health, wellness, and performance products. The company operates through three segments: U.S. and Canada, International, and Manufacturing/Wholesale. Its products include proteins, performance supplements, weight management supplements, vitamins, herbs and greens, wellness supplements, health and beauty products, food and drink products, and other general merchandise. The company also provides third-party contract manufacturing services. It sells its products under the GNC proprietary brands, as well as under third-party brands. As of December 31, 2018, the company had approximately 8,400 locations of which approximately 6,200 retail locations in the United States and franchise operations in approximately 50 countries. It sells its products through company-owned retail stores and its Website GNC.com, as well as third-party Websites; wholesale partnerships; and domestic and international franchise activities. GNC Holdings, Inc. has a strategic partnership with Harbin Pharmaceutical Group Holding Co., Ltd. and International Vitamin Corporation. The company was founded in 1935 and is headquartered in Pittsburgh, Pennsylvania.